Compare BridgeBio Pharma Inc (BBIO) vs Corsair Gaming Inc (CRSR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Corsair Gaming Inc — how do they compare? BridgeBio Pharma Inc trades at $83.86 (market cap $16.36B), while Corsair Gaming Inc trades at $12.95 (market cap $1.39B). The key difference: BridgeBio Pharma Inc is far larger — about 11.8× Corsair Gaming Inc's market cap. Which is the better fit depends on your goals.
| BBIO | CRSR | |
|---|---|---|
Market Cap | $16.36B | $1.39B |
Sector | Health | Technology |
52-Week High | $90.17 | $14.35 |
52-Week Low | $47.29 | $4.58 |
Enterprise Value | $18.14B | $1.38B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Corsair Gaming Inc
Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue generating segment
Read more on CRSR →
